Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that the Company has appointed Minnie Baylor-Henry to the Board of Directors, effective August 1, 2019. Ms. Baylor-Henry will serve as a Director and as Chair of the newly-created Regulatory and Compliance Committee.
“Ms. Baylor-Henry is an accomplished professional in the healthcare industry with over 20 years of experience in Regulatory Affairs, including leadership positions at both large global medical device companies and the U.S. Food & Drug Administration,” said Charlie Goodwin, Chief Executive Officer. “I’m very pleased to welcome her to our Board and look forward to her strategic insight and guidance as the Chairman of our new Regulatory and Compliance Committee.”
Ms. Baylor-Henry currently provides strategic regulatory support to healthcare companies on a consulting basis. From 1999 until 2015, she worked in Regulatory Affairs at Johnson & Johnson and its subsidiaries, McNeil Consumer Health Care and RW Johnson Pharmaceutical Research and Development Corporation. During this period, she held a series of leadership roles of increasing responsibility, culminating in her promotion to Worldwide Vice President of Regulatory Affairs for Johnson & Johnson’s Medical Devices business. Ms. Baylor-Henry also worked as a National Director at Deloitte & Touche in the Regulatory Affairs Life Science practice, which is part of their Audit and Enterprise Risk Services. From 1991 until 1999, Mr. Baylor-Henry worked for the U.S. Food & Drug Administration (“FDA”), where she served as a Director and Branch Chief of the FDA’s Division of Drug Marketing, Advertising and Communications. Ms. Baylor-Henry holds a B.S. in Pharmacy from Howard University’s College of Pharmacy and a J.D. from Catholic University of America’s Columbus School of Law in Washington, D.C. – Business Wire